tiprankstipranks
Advertisement
Advertisement

CHRS Stock Latest News

Coherus Biosciences Signals Momentum in Earnings Call
Company AnnouncementsCoherus Biosciences Signals Momentum in Earnings Call
6d ago
CHRS
Coherus Biosciences Signals Confident Oncology Earnings Outlook
PremiumCompany Announcements
Coherus Biosciences Signals Confident Oncology Earnings Outlook
13d ago
CHRS
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
14d ago
CHRS
Coherus Oncology reports Q1 EPS (28c), consensus (26c)
PremiumThe Fly
Coherus Oncology reports Q1 EPS (28c), consensus (26c)
14d ago
CHRS
Guggenheim starts Coherus with Buy on anti-tumor potential
PremiumThe Fly
Guggenheim starts Coherus with Buy on anti-tumor potential
15d ago
CHRS
Coherus Oncology initiated with a Buy at Guggenheim
PremiumThe FlyCoherus Oncology initiated with a Buy at Guggenheim
15d ago
CHRS
CHRS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CHRS Earnings this Week: How Will it Perform?
28d ago
CHRS
Coherus BioSciences Charts Leaner Path After Earnings Call
Premium
Company Announcements
Coherus BioSciences Charts Leaner Path After Earnings Call
2M ago
CHRS
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
PremiumRatings
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
2M ago
CHRS
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
PremiumRatings
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
3M ago
CHRS
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
PremiumThe Fly
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
3M ago
CHRS
Options Volatility and Implied Earnings Moves Today, March 09, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 09, 2026
3M ago
DDD
HPE
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CHRS
Coherus Biosciences Completes $47 Million Equity Offering
Premium
Company Announcements
Coherus Biosciences Completes $47 Million Equity Offering
3M ago
8K
CHRS
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
Premium
The Fly
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
3M ago
CHRS
Coherus Oncology announces common stock offering, no amount given
PremiumThe Fly
Coherus Oncology announces common stock offering, no amount given
3M ago
CHRS
Coherus Signs Clinical Supply Deal With Janssen Oncology
PremiumCompany Announcements
Coherus Signs Clinical Supply Deal With Janssen Oncology
4M ago
8K
CHRS
Coherus Biosciences Updates ATM Equity Offering Program
PremiumCompany Announcements
Coherus Biosciences Updates ATM Equity Offering Program
4M ago
8K
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
PremiumThe Fly
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
4M ago
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer
PremiumThe FlyCoherus Oncology initiated with an Outperform at Oppenheimer
4M ago
CHRS
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
Premium
The Fly
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
5M ago
CHRS
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
Premium
Ratings
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
6M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >